Skip to content
Screener

BioSig Technologies, Inc. STEX Q3 2025 earnings

Reported November 14, 2025 · Before market open

EPS-$0.47Miss by $0.44
EPS estimate-$0.03

Next report

Nov 12, 2026 (in 2 months)
Revenue estimate$300.0K
EPS estimate-$0.03

Financials

Q3 2025

Income statement

See full
Operating income-$6.1M-107%
Net income-$15.6M-714%
EPS (diluted)-$0.47-292%

Balance sheet

See full
Cash & equivalents$11.0M+1,696%
Total equity-$7.0M-1,618%
Total assets$130.5M+9,104%

Cash flow

See full
Operating cash flow-$5.0M-237%

FAQ

When did BioSig Technologies, Inc. report Q3 2025 earnings?
BioSig Technologies, Inc. (STEX) reported Q3 2025 earnings on November 14, 2025 before market open.
What were BioSig Technologies, Inc.'s Q3 2025 revenue and EPS?
BioSig Technologies, Inc. reported eps of $-0.47 for Q3 2025.
Did BioSig Technologies, Inc. beat estimates in Q3 2025?
EPS missed the consensus estimate of $-0.03 by $0.44.
How did BioSig Technologies, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 297.8% from $-0.12.
Where can I find BioSig Technologies, Inc.'s Q3 2025 SEC filings?
You can read the 10-Q periodic report (0001493152-25-023661) directly on SEC EDGAR. The filing index links above go to sec.gov.